Etosafe ER Tablet contains Etodolac 600mg, a nonsteroidal anti-inflammatory drug (NSAID) used primarily to relieve pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. Etodolac works by inhibiting the cyclooxygenase (COX) enzymes, which play a key role in the synthesis of prostaglandins, substances responsible for pain, fever, and inflammation in the body. The extended-release (ER) formulation of Etosafe ensures a gradual and sustained release of the active ingredient, providing prolonged relief from symptoms while minimizing the frequency of dosing, thereby improving patient compliance. It is typically prescribed to manage moderate to severe pain and inflammation, helping improve joint function and mobility. Patients should take Etosafe ER Tablet with food or milk to reduce gastrointestinal irritation, a common side effect of NSAIDs. It is important to use this medication under medical supervision, especially in individuals with a history of gastrointestinal ulcers, cardiovascular disease, kidney or liver impairment, or those taking other medications that may interact adversely. Common side effects may include nausea, dizziness, and abdominal discomfort. Immediate medical attention is advised if symptoms such as chest pain, shortness of breath, or severe allergic reactions occur.